Pfizer Announces European Approval for Blood Thinner

by Kathy Jones on  May 24, 2011 at 10:57 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

American pharmaceutical giant Pfizer announced that it has gained the approval from the European Commission to market its newest blood thinner drug in the European market.
 Pfizer Announces European Approval for Blood Thinner
Pfizer Announces European Approval for Blood Thinner

The apixaban based drug will be marketed under the brand name Eliquis and is expected to rack up annual sales of over $2.5 billion. Eliquis is expected to provide stiff competition to warfarin, a popular blood thinner used in Europe, given that the drug is known to cause some serious side effects in patients.

According to Pfizer, Eliquis will be given to patients who have undergone hip and knee replacement surgeries in order to prevent venous thromboembolic events (VTE) and is the first oral direct Factor Xa inhibitor drug to be approved by the European authorities.

"The approval of Eliquis provides a new oral option for patients in the EU undergoing elective hip or knee replacement surgery, where the risk of bleeding is a significant concern", Pfizer's Olivier Brandicourt said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Thalassemia Congenital Heart Disease Top Ten Selling Drugs Anticoagulants Blood in Stools - Symptom Evaluation Bombay Blood Group 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive